An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection

Roche

Status: Completed

Conditions: HIV Infections

Study type: Observational

Funder types: Industry

Identifiers

NCT01902615

ML25313

Details and patient eligibility

About

This multicenter, retrospective, observational study will evaluate the therapeutic effectiveness of a strategy of induction with Fuzeon (enfuvirtide) within an optimized regimen of antiretroviral drugs in patients with HIV-1 infection in routine clinical practice.

Enrollment: 58 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/= 18 years of age
• HIV-1+ infection
• Patients with a viral load > 50 copies/ml who have received induction treatment with Fuzeon in combination with antiretroviral treatment
• Naïve for Fuzeon at initiation of induction treatment
• Antiretroviral treatment of at least 12 months duration

Exclusion criteria

• Patients who did not receive Fuzeon treatment

Trial design

58 participants in 1 patient group

Cohort